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ABSTRACT
Female rats 4 weeks old were fed diets including beef tallow or safflower oil in
combination with sucrose or rice starch. At 8 weeks of age, half the rats were orally
administered 2 of estrogen (mestranol) in5 Ml of safflower oil and half were fed the
vehicle only. After 10 to 14 days of estrogen treatment, rats were fasted and exsanguinated.
Alterations were found in weight gain, liver weights, and levels of various lipids inplasma
and liver.Most lipid levels were influenced by an interaction of mestranol with one of the
dietary factors. No changes were observed in blood clotting activity as measured by
prothrombin time and levels of plasma fibrinogen.
INTRODUCTION
Oral contraceptives (OCs) are known to elevate plasma lipids and
to increase thromboembolism in women (Mann et al. 1975). It is
possible that certain dietary histories predispose women to
thrombosis. Estrogens from OCs may act synergistically with certain
dietary patterns. Plasma and liver lipids and blood clotting activity in
rats are known to be influenced by the interaction of OCs with
dietary fat (Tabacchi and Kirksey 1973). Plasma and liver lipids are
known tobe influenced by type of carbohydrate fed with various fats
(Carroll and Bright 1965). The purpose of this investigation was to
study liverand plasma lipidlevels and blood clotting activityofyoung
female rats treated with estrogen and fed diets of varied fat-
carbohydrate composition.
MATERIALS ANDMETHODS
The experiment was designed as a 2 X2 X2 factorial with 5or 6 rats
to each of 8 treatment combinations. Experimental variables were
the type ofdietary fat. beef tallow (BT)or safflower oil (SO): the type
ofdietary carbohydrate, sucrose (S) or rice starch (RS); and estrogen
treatment, with mestranol 1(+M)orwithout mestranol (-M).
At 4 weeks of age, female rats of the Sprague-Dawley 1strain were
assigned at random to treatment groups. Ina temperature controlled
room, rats were housed individually in wire-bottomed cages where
they had free access to water and ration (Table I).At 8 weeks of age.
half the rats fed each of the 4diets were orally administered .' /< t: <>l
mestranol, a common estrogen in OCs, in 5 M1 of safflower oil and
half were fed the vehicle only. This quantity of mestranol is
approximately the minimum dosage of estrogen used in combination
with a progestin to prevent conception in rats (Aftergood and Allin
Slater 1971). In proportion to body weight, this dosage in rats is
approximately 10 times the quantity ofestrogen taken by women who
use OCs.
After 10 to 14 days of estrogen treatment, rats were fasted for 4
hours, anesthetized with sodium pentobarbital, and exsanguinated
from the abdominal aorta. Liver and plasma were assayed for lipid
content. Triglyceride was assayed by the method of Mendez et al.
(1975). The method of Zlatkis et al. (1953) was used to determine
cholesterol. Phospholipid was hydrolyzed by the method of Young-
berg and Youngberg (1930), and the inorganic phosphorus thus
released was determined by the method of Fiske and Subbarow
(1925). Plasma coagulation properties assayed were prothrombin
time (Faulkner and King 1970) and level of plasma fibrinogen
(Ratnoff and Menzie 1964). Data were examined by analysis of
variance in a completely random design. Significance was
determined from /"-values.
'Amersham Searle Chemicals, Inc., Chicago, Illinois.
'Hormone Assay Laboratories, Chicago, Illinois.
RESULTS ANDDISCUSSION
Mestranol depressed weight gain by 46% (Table II). Rats treated
with mestranol not only ate less ration than did their counterparts,
but also used food consumed less efficiently for weight gain. Rats fed
SO had heavier livers inrelation to body weight than did those fed
BT.Relative liver weights of rats treated withmestranol were greater
because of lower body weights. Values forliverlipidswere stated per
100 mg of liver protein in order to make comparisons unaffected by
liver or body weights.
Total liver lipids and liver triglycerides were altered by an inter-
action of the carbohydrate and estrogen factors (Fig. la, b). Without
mestranol, liver lipid was greater when the dietary carbohydrate was
RS rather than S. However, when the treatment included mestranol.
RS was unable to elevate total liver lipidsand triglycerides.
It is not clear why, in the absence of mestranol, RS but not S
elevated liver lipids.Carroll and Bright (1965), who fed low carbohy-
drate-high fat diets, found that accumulation of liver lipidsinmale
rats was dependent on both the type of carbohydrate and the type of
fat fed. In that study, liver lipid was decreased when rats were fed
fructose with corn oilrather than glucose with corn oil,or either
carbohydrate withhydrogenated coconut oil.
The fate of RS in the presence of mestranol is unknown. Cortisol,
which increases gluconeogenesis and inhibits fatty acid synthesis in
the liver, is known to be elevated in plasma of rats treated with
mestranol (Renaud 1970). Perhaps glucose from RS undergoes
lipogenesis in the absence of mestranol but is utilized by cells or
converted to glycogen inthe presence of mestranol.
Livercholesterol was elevated by SO and by the interaction of SO
with RS, regardless of whether or not mestranol was administered(Fig. lc).Plasma cholesterol was depressed by mestranol, an action
independent of the type of fat or carbohydrate fed (Table III).Thus,
the elevation of liver cholesterol and the depression of plasma
cholesterol were unrelated and not the result of transfer from plasma
to liver.
Plasma phospholipids were elevated by BTover SO, and depressed
by the interaction of SO with mestranol. Although mestranol had no
influence on plasma phospholipids when the dietary fat was BT.
phospholipids were greatly decreased by mestranol when SO was fed
(Fig. Id). Aftergood and Alfin-Slater (1971) reported that plasma
phospholipids were decreased in female rats fed a stock diet and
treated withan OC.
Plasma cholesterol and plasma phospholipids of rats were
depressed in this experiment by mestranol or by an interaction that
included mestranol. Yet these lipids commonly are elevated in the
plasma of women who take OCs. In contrast, plasma triglycerides
seem to be elevated in both women and rats by most OCs and by
estrogen. Although plasma triglycerides were not measured in this
study, it is suspected that this lipidwas elevated by mestranol (Kekki
and Nikkila 1971, Tabacchi and Kirksey 1973, Kudzma et al. 1975).
The liverof an estrogen-fed animal is likelytobe overburdened with
fatty acids because estrogen elevates plasma cortisol levels and
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Figure 1. Interaction means ofliver and plasma lipids. RS = rice starch. S = sucrose, -M = without mestranol, +M = with mestranol. SO =
safflower oil, BT =beef tallow.
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Liver lipids Plasma lipids
Total Triglyc-
Lipid eride
Choles-
terol
Choles- Phospho-
terol lipid
mg/100 mg liver protein nig/100 ml plasma
Fat
BT1 24.67
26.41
6.80
5.29
2.29
3.13
95.1
89.9
137
SO 118
Carbohydrate
S 94.0
91.0
12822.78
28.45
4.55
7.70
2.45
2.95 127RS
Estrogen
-M 27.47
23.68
7.43
4.75
2.72
2.67
102.4
83.1
132
+M 124
Significant F values
(P< 0.005) CHO, Est, CHO, Est, Fat, CHO,
CHO X Est CHO X Est
Est Fat
(P< 0.05) Fat X CHO Fat X Est
*
BT = beef tallow, SO = safflower oil, S = sucrose, RS = rice starch,
-M = without mestranol, +M = with mestranol.
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